Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

Annals of Hematology
Bruno C MedeirosCarolina Reyes

Abstract

Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older. We examined patient characteristics, treatment patterns, and survival among elderly patients in routine clinical practice. We utilized a retrospective cohort analysis of first primary AML patients in the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database. Patients were diagnosed between January 1, 2000 and December 31, 2009, >66 years, and continuously enrolled in Medicare Part A and B in the year prior to diagnosis. Kaplan-Meier curves and Cox proportional hazards regression assessed overall survival by treatment. There were 3327 (40 %) patients who received chemotherapy within 3 months of diagnosis. Treated patients were more likely younger, male, and married, and less likely to have secondary AML and poor performance indicators and comorbidity score compared to untreated patients. In multivariate survival analysis, treated patients exhibited a significant 33 % lower risk of death compared to untreated patients. Significant survival benefits were noted with receipt of intensive and hypomethylating agent (HMA) therapies compared to no therapy. A survival benefit with allogeneic hematopoietic stem cell transplantati...Continue Reading

References

Dec 30, 1999·The New England Journal of Medicine·L F HutchinsK S Albain
Mar 7, 2002·Journal of the National Cancer Institute·Vickie L Shavers, Martin L Brown
Jun 13, 2002·Reviews in Clinical and Experimental Hematology·Thomas BüchnerUNKNOWN German AML Co-Operative Group
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine MengisMartin F Fey
Jun 10, 2004·JAMA : the Journal of the American Medical Association·Vivek H MurthyCary P Gross
Jul 22, 2004·Journal of the National Cancer Institute·C P GrossH M Krumholz
Dec 6, 2005·Drugs & Aging·Kathleen LangJoseph Menzin
Dec 6, 2005·Leukemia·G JuliussonUNKNOWN Swedish Adult Acute Leukemia Registry Group
Feb 4, 2006·Blood·Frederick R AppelbaumStephen H Petersdorf
Mar 6, 2007·Best Practice & Research. Clinical Haematology·Rainer Storb
Nov 3, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Geoffrey R OxnardLecia V Sequist
Dec 7, 2007·American Journal of Epidemiology·Samy Suissa
Dec 8, 2007·Cancer Causes & Control : CCC·Jennifer F Yamamoto, Marc T Goodman
Dec 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre FenauxLewis R Silverman
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy J DavidoffMartin J Edelman
Jul 10, 2012·Haematologica·Betul Oran, Daniel J Weisdorf
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan K BurnettDonald Milligan
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 16, 2013·Journal of the Egyptian National Cancer Institute·Gehan H Ibrahim
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ayal A AizerPaul L Nguyen

❮ Previous
Next ❯

Citations

Sep 15, 2015·Expert Opinion on Pharmacotherapy·Ryan C Lynch, Bruno C Medeiros
Nov 9, 2015·PharmacoEconomics·Paula K LorgellyUNKNOWN Cancer 2015 Investigators
Feb 16, 2016·Expert Review of Hematology·Jay Yang, Charles A Schiffer
May 15, 2016·Current Hematologic Malignancy Reports·Gustavo F WestinRonald S Go
Jul 14, 2016·Leukemia Research Reports·Antonio M Almeida, Fernando Ramos
Aug 9, 2016·Leukemia Research·Vinay Prasad, Robert Peter Gale
Nov 12, 2016·Leukemia·E Estey, R P Gale
May 29, 2018·Cancer·Martha Arellano, Jennifer Wilkinson Carlisle
Apr 27, 2018·Expert Opinion on Pharmacotherapy·Laura C MichaelisRoland B Walter
Mar 10, 2018·Targeted Oncology·Nadia Khan, Brad Kahl
Dec 27, 2018·Current Opinion in Hematology·Tsila Zuckerman, Jacob M Rowe
Aug 21, 2018·Journal of Medical Economics·May HagiwaraThomas E Delea
Feb 5, 2019·Current Medical Research and Opinion·Bruno C MedeirosL Elise Horvath Walsh
Mar 13, 2019·Genes, Chromosomes & Cancer·Ing S Tiong, Andrew H Wei
Dec 7, 2018·Hematology·Laura C Michaelis
Dec 10, 2017·Hematology·Hervé Dombret, Raphael Itzykson
Apr 18, 2019·JCO Clinical Cancer Informatics·Meghan C Ferrall-FairbanksPhilipp M Altrock
May 22, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael R Savona, Andrew H Wei
Aug 9, 2017·Proceedings of the National Academy of Sciences of the United States of America·Stephen E KurtzJeffrey W Tyner
Aug 18, 2018·Blood·Bruno C Medeiros
Dec 24, 2019·Blood Advances·Daniel A PollyeaMarina Y Konopleva
Jan 3, 2020·Current Opinion in Hematology·Jonathan A Gutman, Daniel A Pollyea
Jan 31, 2016·Current Opinion in Hematology·Laura E Finn, James M Foran
May 16, 2020·Journal of the National Cancer Institute. Monographs·Clara J K LamAngela B Mariotto

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS

Software Mentioned

SEER
SAS

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.